Morpholine → 4-{[7-(Methylsulfonyl)-3,4-dihydro-2H-chromen-2-YL]methyl}morpholine
Reaction equation
CC1C=CC(S(O[CH2:12][CH:13]2[CH2:22][CH2:21][C:20]3[C:15](=[CH:16][C:17]([S:23]([CH3:26])(=[O:25])=[O:24])=[CH:18][CH:19]=3)[O:14]2)(=O)=O)=CC=1.[NH:27]1[CH2:32][CH2:31][O:30][CH2:29][CH2:28]1>C(#N)C>[CH3:26][S:23]([C:17]1[CH:16]=[C:15]2[C:20]([CH2:21][CH2:22][CH:13]([CH2:12][N:27]3[CH2:32][CH2:31][O:30][CH2:29][CH2:28]3)[O:14]2)=[CH:19][CH:18]=1)(=[O:24])=[O:25]Participants
4
Procedure
Preparation according to Example 25: [7-(methylsulfonyl)-3,4-dihydro-2H-chromen-2-yl]methyl 4-methylbenzenesulfonate (0.020 g, 0.0504 mmol), morpholine (0.5 ml), ACN (3 ml). MS m/z (rel. intensity, 70 eV) 311 (M+, 2), 132 (3), 131 (5), 101 (6), 100 (bp), 56 (6).
Workup
- customPreparation
Sources & evidence
- ORD record
- ord-0d09299edfc34b6281efcc1fb6411362
- Source dataset
- uspto-grants-2013_09
- Patent number
- US08524766B2
Reaction notes
Loading…